SEC Form 4 · accession 0000904454-16-001261
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole Vitullo
Director · 10% Owner
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.75 | Jun 9, 2016 | A | 8,000 | A | — | Jun 9, 2026 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1The option vests in full on the earlier of (i) June 9, 2017 or (ii) the Issuer's next annual meeting of stockholders following June 9, 2016, subject to the Reporting Person's continued service on the Board of Directors at such time.